HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

No carcinogenicity of ethyl tertiary-butyl ether by 2-year oral administration in rats.

Abstract
The carcinogenicity of ethyl tertiary-butyl ether (ETBE) was examined by oral administration using F344/DuCrlCrlj rats. Groups of 50 male and 50 female rats were given drinking water containing ETBE at doses of 0, 625, 2,500 or 10,000 ppm (w/w) for 104 weeks. No significant increase in the incidence of tumors was detected in any organ of either sex. Rat-specific non-neoplastic lesions were observed in the kidney: An increase in the severity of chronic progressive nephropathy was observed in the male and female 10,000 ppm groups, and increased incidences of urothelial hyperplasia of the pelvis and mineral deposition in the renal papilla were observed in the male 2,500 and 10,000 ppm groups. Besides these lesions, no treatment-related histopathological changes were observed in any organ or tissue in either sex. Thus, the present study demonstrated that a two year administration ETBE in the drinking water did not exert any carcinogenic effects in either male or female rats.
AuthorsMasaaki Suzuki, Kazunori Yamazaki, Hirokazu Kano, Shigetoshi Aiso, Kasuke Nagano, Shoji Fukushima
JournalThe Journal of toxicological sciences (J Toxicol Sci) Vol. 37 Issue 6 Pg. 1239-46 ( 2012) ISSN: 1880-3989 [Electronic] Japan
PMID23208438 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ethyl Ethers
  • ethyl tert-butyl ether
Topics
  • Administration, Oral
  • Animals
  • Carcinogenicity Tests
  • Dose-Response Relationship, Drug
  • Ethyl Ethers (administration & dosage, toxicity)
  • Female
  • Kidney (drug effects)
  • Kidney Diseases (chemically induced)
  • Male
  • Organ Size (drug effects)
  • Rats
  • Rats, Inbred F344
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: